8
7
7
CURE Act
7/31/2025, 12:05 PM
Summary of Bill HR 4342
The bill titled "To amend the 21st Century Cures Act to improve the administration, oversight, and impact of opioid use disorder grants, and for other purposes" was introduced in the 119th Congress as H.R. 4342 on July 10, 2025. The purpose of this bill is to enhance the management, supervision, and effectiveness of opioid use disorder grants established under the 21st Century Cures Act.
Read the Full Bill
Current Status of Bill HR 4342
Bill HR 4342 is currently in the status of Bill Introduced since July 10, 2025. Bill HR 4342 was introduced during Congress 119 and was introduced to the House on July 10, 2025. Bill HR 4342's most recent activity was Referred to the House Committee on Energy and Commerce. as of July 10, 2025
Bipartisan Support of Bill HR 4342
Total Number of Sponsors
3Democrat Sponsors
0Republican Sponsors
3Unaffiliated Sponsors
0Total Number of Cosponsors
0Democrat Cosponsors
0Republican Cosponsors
0Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 4342
Primary Policy Focus
HealthAlternate Title(s) of Bill HR 4342
CURE Act
CURE Act
Clarity for Opioid-Use Reduction and Expenditures Act
To amend the 21st Century Cures Act to improve the administration, oversight, and impact of opioid use disorder grants, and for other purposes.
Comments
Sponsors and Cosponsors of HR 4342
Latest Bills
SCORE Act
Bill HR 4312December 2, 2025
Made in America Manufacturing Finance Act
Bill HR 3174December 2, 2025
Expanding WKSI Eligibility Act
Bill HR 4430December 2, 2025
Small Business Regulatory Reduction Act of 2025
Bill HR 2965December 2, 2025
HUD Transparency Act of 2025
Bill HR 225December 2, 2025
SBA IT Modernization Reporting Act
Bill HR 4491December 2, 2025
Hospital Inpatient Services Modernization Act
Bill HR 4313December 2, 2025
Investing in All of America Act of 2025
Bill HR 2066December 2, 2025
Improving Capital Allocation for Newcomers Act of 2025
Bill HR 4431December 2, 2025
Claiming Age Clarity Act
Bill HR 5284December 2, 2025
